Report Feature
The future of the neuromodulation market looks promising with opportunities in applications, such as spinal cord stimulation, deep brain stimulation, sacral nerve stimulation, vagus nerve stimulation, gastric electrical stimulation, transcutaneous electrical nerve stimulation, transcranial magnetic stimulation, and respiratory electrical stimulation. The global neuromodulation market is expected to grow with a CAGR of 7%-9% from 2020 to 2025. The major drivers for this market are increasing research and development activities in neurology and growing prevalence of neurological disorders.
A total of XX figures / charts and XX tables are provided in this more than 150-pages report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global neuromodulation market report, please download the report brochure.
In this market, internal neuromodulation is the largest technology of neuromodulation, whereas wastewater is the largest application. Growth in various segments of the neuromodulation market are given below:
The study includes trends and forecast for the global neuromodulation market by technology, biomaterial, application, and region as follows:
By Technology [Value ($ Million) shipment analysis for 2014 – 2025]:
- Internal Neuromodulation
- Spinal Cord Stimulation
- Deep Brain Stimulation
- Vagus Nerve Stimulation
- Sacral Nerve Stimulation
- Gastric Electrical Stimulation
- External Neuromodulation
- Transcutaneous Electrical Nerve Stimulation (TENS)
- Transcranial Magnetic Stimulation (TMS)
- Respiratory Electrical Stimulation (RES)
By Biomaterial [Value ($ Million) shipment analysis for 2014 – 2025]:
- Metallic Biomaterials
- Polymeric Biomaterials
- Ceramic Biomaterials
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
- Spinal Cord Stimulation
- Deep Brain Stimulation
- Sacral Nerve Stimulation
- Vagus Nerve Stimulation
- Gastric Electrical Stimulation
- Transcutaneous Electrical Nerve Stimulation
- Transcranial Magnetic Stimulation
- Respiratory Electrical Stimulation
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
-
North America
- United States
- Canada
- Mexico
-
Europe
- United Kingdom
- Spain
- German
- France
-
Asia Pacific
- China
- India
- Japan
-
The Rest of the World
- Brazil
Some of the neuromodulation model companies profiled in this report include Medtronic, Boston Scientific, Abbott, LivaNova, Synapse Biomedical, Nevro, NeuroSigma, NeuroPace, Neuronetics, and BioControl Medical.
Lucintel forecasts that internal neuromodulators will remain the largest product segment over the forecast period due to rising prevalence of neurological disorders, increasing research into expanding the applications of neuromodulation, and awareness of neurodegenerative disorders.
Within this market, deep brain stimulation will remain the largest application segment over the forecast period due to the rising incidence of generic diseases and growing R&D activity for neuromodulation applications.
North America will remain the largest region over the forecast period due to rise in geriatric population, their vulnerability for neurological disorders, increase in incidence of neurological diseases, such as Alzheimer’s and Parkinson’s diseases, and the increase in awareness of the safety and efficacy of neurostimulator devices in the region.
|
Features of the Global Neuromodulation Market |
|
|
This report answers following key questions |
|
Q.1 What are some of the most promising potential, high-growth opportunities for the global neuromodulation market by technology (internal neuromodulation (spinal cord stimulation, deep brain stimulation, vagus nerve stimulation, sacral nerve stimulation, and gastric electrical stimulation) and external neuromodulation (transcutaneous electrical nerve stimulation (TENS), transcranial magnetic stimulation (TMS), and respiratory electrical stimulation (RES))), biomaterial (metallic biomaterials, polymeric biomaterials, and ceramic biomaterials), application (spinal cord stimulation, deep brain stimulation, sacral nerve stimulation, vagus nerve stimulation, gastric electrical stimulation, transcutaneous electrical nerve stimulation, transcranial magnetic stimulation, and respiratory electrical stimulation), and region (North America, Europe, Asia Pacific, and Rest of the World)? Q.2 Which segments will grow at a faster pace and why? Q.3 Which region will grow at a faster pace and why? Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global neuromodulation market? Q.5 What are the business risks and threats to the global neuromodulation market? Q.6 What are the emerging trends in this neuromodulation market and the reasons behind them? Q.7 What are some changing demands of customers in this neuromodulation market? Q.8 What are the new developments in this neuromodulation market? Which companies are leading these developments? Q.9 Who are the major players in this neuromodulation market? What strategic initiatives are being implemented by key players for business growth? Q.10 What are some of the competitive products and processes in this neuromodulation market, and how big of a threat do they pose for loss of market share via material or product substitution? Q.11 What M&A activities did take place in the last five years in the global neuromodulation market? |
Report Scope
| Key Features | Description |
| Base Year for Estimation | 2019 |
|
Trend Period (Actual Estimates) |
2014-2019 |
| Forecast Period | 2020-2025 |
| Pages | More than 150 |
| Market Representation / Units | Revenue in US $ Million |
| Report Coverage | Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling |
| Market Segments | Technology (Internal Neuromodulation (Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation, and Gastric Electrical Stimulation) and External Neuromodulation (Transcutaneous Electrical Nerve Stimulation (TENS), Transcranial Magnetic Stimulation (TMS), and Respiratory Electrical Stimulation (RES))), Biomaterial (Metallic Biomaterials, Polymeric Biomaterials, and Ceramic Biomaterials), and Application (Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Gastric Electrical Stimulation, Transcutaneous Electrical Nerve Stimulation, Transcranial Magnetic Stimulation, and Respiratory Electrical Stimulation) |
Regional Scope |
North America (USA, Mexico, and Canada), Europe (United Kingdom, Spain, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil) |
| Customization | 10% Customization without Any Additional Cost |
Table of Contents
1. Executive Summary
7.2 Emerging Trends in the Global Neuromodulation Market
4.1 Global Neuromodulation Market by Region
4.2.1 Market by Technology: Internal Neuromodulation (Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation, and Gastric Electrical Stimulation) and External Neuromodulation (Transcutaneous Electrical Nerve Stimulation (TENS)
4.2.2 Market by Biomaterial: Metallic Biomaterials, Polymeric Biomaterials, and Ceramic Biomaterials
4.2.3 Market by Application: Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Gastric Electrical Stimulation, Transcutaneous Electrical Nerve Stimulation, Transcranial Magnetic Stimulation, and Respiratory Electrical Sti
4.2.4 The United States Neuromodulation Market
4.2.5 The Canadian Neuromodulation Market
4.2.6 The Mexican Neuromodulation Market
4.3.1 Market by Technology: Internal Neuromodulation (Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation, and Gastric Electrical Stimulation) and External Neuromodulation (Transcutaneous Electrical Nerve Stimulation (TENS)
4.3.2 Market by Biomaterial: Metallic Biomaterials, Polymeric Biomaterials, and Ceramic Biomaterials
4.3.3 Market by Application: Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Gastric Electrical Stimulation, Transcutaneous Electrical Nerve Stimulation, Transcranial Magnetic Stimulation, and Respiratory Electrical Sti
4.3.4 The United Kingdom Neuromodulation Market
4.3.5 The Spanish Neuromodulation Market
4.3.6 The German Neuromodulation Market
4.3.7 The French Neuromodulation Market
4.4.1 Market by Technology: Internal Neuromodulation (Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation, and Gastric Electrical Stimulation) and External Neuromodulation (Transcutaneous Electrical Nerve Stimulation (TENS)
4.4.2 Market by Biomaterial: Metallic Biomaterials, Polymeric Biomaterials, and Ceramic Biomaterials
4.4.3 Market by Application: Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Gastric Electrical Stimulation, Transcutaneous Electrical Nerve Stimulation, Transcranial Magnetic Stimulation, and Respiratory Electrical Sti
4.4.4 The Chinese Neuromodulation Market
4.4.5 The Indian Neuromodulation Market
4.4.6 The Japanese Neuromodulation Market
4.5.1 Market by Technology: Internal Neuromodulation (Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation, and Gastric Electrical Stimulation) and External Neuromodulation (Transcutaneous Electrical Nerve Stimulation (TENS)
4.5.2 Market by Biomaterial: Metallic Biomaterials, Polymeric Biomaterials, and Ceramic Biomaterials
4.5.3 Market by Application: Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Gastric Electrical Stimulation, Transcutaneous Electrical Nerve Stimulation, Transcranial Magnetic Stimulation, and Respiratory Electrical Sti
4.5.4 Brazilian Neuromodulation Market
7.1.1 Growth Opportunities for the Global Neuromodulation Market by Technology
7.1.2 Growth Opportunities for the Global Neuromodulation Market by Biomaterial
7.1.3 Growth Opportunities for the Global Neuromodulation Market by Application
7.1.4 Growth Opportunities for the Global Neuromodulation Market by Region
Methodology
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
- In-depth interviews of the major players in this market
- Detailed secondary research from competitors’ financial statements and published data
- Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
- A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
Buy Now
Choose a license that fits your team. Instant PDF delivery.
Prices exclude taxes. Instant delivery. Custom licensing available on request.
